The weight-loss drugs that took the world by storm a few years ago have a drawback for anyone afraid of needles: they must be injected weekly. But scientists have been racing to perfect anti-obesity ...

Blockbuster weight-loss drugs are transforming the way we treat obesity. But while costly injectable versions remain out of reach for many, newly approved tablet forms are expected to significantly ...

Viagra can help men rise to the occasion, and so much more. For decades, there seemed to be one straightforward benefit of taking erection pills — an easy way for men to get it up and get it on. But ...

“All I have is sperm,” Akash Bakshi says. “I’m just looking at sperm counts.” Every day the co-founder of YourChoice Therapeutics arrives at his startup’s office in San Francisco to do this work. A ...

SAN FRANCISCO, Jan 12 (Reuters) - Oral weight-loss drugs could account for a third or more of the overall GLP-1 market by 2030, a Novo Nordisk (NOVOb.CO), opens new tab executive said on Monday, a ...

The indictment, followed by a request to extradite the doctor from California, is an escalation of Louisiana’s efforts to counter states that support providing abortions. By Emily Cochrane and Pam ...

The first effective weight-loss pills should hit the market this year, but expect lots of other news in obesity drugs this year, said a Guggenheim Securities note Sunday.

In 2026, new obesity pills will push the booming GLP-1 market into its next chapter. Pills may serve as a more convenient — and in certain cases cheaper — alternative to today's blockbuster injections ...

Danish drugmaker Novo Nordisk is launching its once-daily Wegovy pill in the United States on Monday, offering 1.5 milligram and 4 mg doses at $149 per month for self-paying patients in an intensely ...

Americans can now purchase the starter dose of blockbuster weight-loss drug Wegovy as a pill, drug maker Novo Nordisk announced Monday. Other strengths will be available as pills by the end of the ...

The ripple is about to become a wave. Right now, there are numerous barriers for people who are considering treating their obesity with GLP-1 drugs. Early on, there were manufacturing bottlenecks that ...

LONDON, Dec 29 (Reuters) - Ask executives in the healthcare industry about the future market for weight-loss drugs and the analogies are telling: monthly GLP-1 medicine subscriptions like a streaming ...